Clinical Trial

RAdiation SEgmentectomy With REsin Microspheres (RASEREM) Study

Study acronym: RASEREM
Recruiting
View on ClinicalTrials.gov →
Summary
Radiation segmentectomy (RS) refers to selective infusion of Y-90 microspheres to the tumor bearing hepatic segment of hepatic artery. Majority of the data on RS is based on the Glass microspheres experience. Due to different properties of Resin and Glass microspheres description of dose limits to the segment for effectiveness of treatments with Resin microspheres are needed. Based on this background in this study it is aimed to evaluate the safety and efficacy of RS with resin microspheres in HCC patients. Secondly, it is planned to describe the dose limits for complete radiological response.
Protocol Amendment History 1 amendment
This ClinicalTrials.gov record has been amended once since 2026-01-09.
Trial Details
NCT Number NCT07345247
Lead Sponsor Ankara University
Collaborators: Sirtex Medical
Conditions Liver Cancer, Adult
Enrollment 150 participants
Start Date 2025-08-01
Primary Completion 2028-03-01 (estimated)
Study Completion 2028-08-01 (estimated)
Updated on ClinicalTrials.gov 2026-01-22